We have recently shown that group B Streptococcus (GBS) crosses the epithelial barrier by a paracellular route. Here, we show that, although deletion of the pilus backbone protein did not affect GBS adhesiveness, it reduced the pathogen's capacity to transcytose through differentiated human epithelial cells. In addition, contrary to our expectation, a strain with a mutant pilus ancillary protein and reduced adhesiveness translocated through the epithelial monolayer in a fashion identical to that of the isogenic wild-type strain. To monitor the localization of pili during GBS paracytosis, we performed 3-dimensional confocal experiments. By this approach, we observed that pili located in the intercellular space ahead of translocating bacteria. These results were also confirmed by a novel in vitro model of GBS infection in which bacteria bind to epithelial surfaces against the action of gravitation. These findings suggest a dual role for pilus components during the critical steps leading to GBS dissemination in the host.
Pilus-like structures have only recently been described in gram-positive pathogens [1] [2] [3] [4] . The proteinaceous components of the structures are covalently polymerized by the action of sortase enzymes similar to those involved in the covalent attachment of gram-positive surface proteins to the peptidoglycan cell wall [5] . With great relevance to the development of strategies to combat infections associated with gram-positive organisms, pilus components have been shown to induce protective immunity in mouse models of streptococcal disease [6 -8] . We have recently shown [2] that group B Streptococcus (GBS) genes coding for high molecular weight, covalently linked pilus-like structures are part of an operon that codes for 3 LPXTG proteins and 2 sortases and have a similar organization to the genes coding for Corynebacterium diphtheriae pilus-like structures [1] . Two pilus island (PI) variants, PI-1 and PI-2, have been described, with the latter differentiated into components 2a and 2b [3] . The backbone protein of pilus 1 (BP-1 [GBS80]) and the ancillary protein 1 of pilus 1 (AP1-1 [GBS104]) are the major components of PI-1 pili. Transmission electron micrographs showed that antibodies specific for BP-1 decorated long pilus-like structures, whereas antibodies specific for AP-1 showed intermittent staining along the structures and around the surface of the bacteria. Of interest, the ancillary protein 2 of pilus 1 (AP2-1 [GBS52]), although coprecipitating with the other 2 pilus components was not visualized on the bacterial surface [3] .
Application of this approach to PI-2a LPXTG components led to the identification of a pilus backbone protein (BP-2a [GBS59]) and 2 pilus ancillary proteins, AP1-2a (GBS67) and AP2-2a (GBS150). These findings were further supported by the fact that BP-2a and AP1-2a share a significant amino acid sequence similarity with PI-1 backbone and ancillary proteins, respectively. The GBS pilus proteins have sequence similarity with a family of extracellular matrix binding proteins known as microbial surface components that recognize adhesive matrix molecules, some of which have been demonstrated to be involved in adhesion to and invasion of host cells [9] . GBS proteins involved in pilus formation facilitate the interaction of this pathogen with endothelial cells of the human blood-brain barrier [10] . This is in agreement with the model proposed by Telford et al. [4] that gram-positive pilus-like structures are important for host colonization. Here, we provide evidence for an active role of pilus backbone proteins coded by both PI-1 and PI-2a loci in the recently discovered paracellular translocation used by GBS to pass through the epithelial barrier [11] . In addition, we propose a model for GBS in vivo invasiveness that is based on pilusmediated transcytosis through mucosal surfaces.
MATERIALS AND METHODS
Cell culture. The human cervical epithelial cell line ME180 was purchased from the ATCC (Rockville, MD). Cells were maintained in RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (FBS). The human colon carcinoma epithelial cell line Caco2 and the human lung carcinoma epithelial cell line A549 were also supplied by the ATCC and grown in DMEM supplemented with 10% FBS, 4.5g/L glucose, and nonessential amino acids.
Bacterial strains. Wild-type bacterial strains included COH1, a serotype III strain, and 515, a serotype Ia strain, both of which are described elsewhere [12, 13] . Construction of inframe deletion mutations and of complementation plasmids were previously reported by our group [3] . We performed association and transcytosis assays, using COH1⌬BP-1, a BP-1 mutant strain; COH1⌬AP1-1, an AP-1 mutant strain; 515⌬BP-2a, a BP-2a mutant strain; and 515⌬AP1-2a, an AP1-2a mutant strain. For infection experiments, bacteria were grown in fresh Todd-Hewitt broth medium at 37°C until they reached an OD 600 of 0.4.
Cloning, expression, and purification of recombinant proteins. DNA from GBS strain 2603 V/R (serotype V) was used for cloning the sequences coding for the LPXTG proteins present in PI-1 (The Institute for Genome Research  [TIGR] . Recombinant proteins were expressed in Escherichia coli BL21DE3 cells (Novagen) as 6His-tagged fusion proteins by cloning the corresponding genes in pET24bϩ (Novagen) and were purified by affinity chromatography as reported elsewhere [3] . Protein purity after 3 chromatographic steps was Ͼ98%. Antisera specific for the recombinant proteins were produced by immunizing CD1 mice with the respective purified recombinant proteins [6] .
Fluorescence-activated cell sorter (FACS) analysis of the binding of recombinant pilus components to epithelial cells. Epithelial cells were mixed with 0.1, 1, and 10 g/mL of recombinant pilus components and incubated for 1 h at 4°C. Cells were subsequently incubated for 45 min at 4°C with the specific rabbit antiserum in 5% FCS, and binding was revealed by R-Phycoerytrin (PE)-conjugated secondary antibodies (Jackson Immuno Research) at 4°C. Cell-bound fluorescence was analyzed by a FACSscan flow cytometer (Becton Dickinson). Changes in the mean fluorescence intensity of cells incubated with or without proteins were compared.
Adhesion assay. Cells in 24-well plates were infected with ϳ10 bacteria/cell in infection medium (i.e., basal medium without antibiotics) supplemented with 2% FBS in 300-L volumes. At the end of a 2-h incubation period at 37°C in 5% CO 2 (v/v), wells were washed, and the total number of colony-forming units (cfu) was estimated after addition of 1% saponin to the well's contents. Adhesiveness was quantified by determining the ratio of cell-associated cfu versus total cfu present in the assay.
Transcytosis assay. ME180 epithelial cells were cultured on Falcon transwell filters (the pore size was 3 mol/L to allow the passage of bacteria) in 24-well dishes. Transepithelial electric resistance across the cell monolayer was measured every 3-4 days, and the cells were used when a plateau was reached (ϳ300 ⍀/cm 2 for ME180 cells). Cells were then inoculated with ϳ10 bacteria/cell in the upper-chamber medium for 2 h, after which nonadherent bacteria were removed by 3 washes in infection medium. After infection, lower-chamber medium was collected, and samples were used to calculate the number of viable bacteria that had crossed the monolayer. The transcytosis percentage was calculated as the number of bacteria collected in the lower chamber divided by the number of bacteria inoculated in the upper chamber.
"Inverse-infection" protocol and confocal microscopy. In so-called inverse-infection experiments, PET transwell inserts (pore size, 0.4 mol/L) with confluent ME180 cells were inserted upside down in a 14-mL test tube containing a bacterial suspension of 10 7 bacteria/mL. This method ensured that the apical surface of cells was in contact with floating bacteria. A filtered tip was positioned on top of the transwell, with the filter pad presoaked in infection buffer to increase tip weight. To maintain bacteria in suspension and allow contact with cells, the tube was fixed on a rotating device set at 150 g. Infection at these conditions lasted for 2 h, after which cells were washed 3 times and infection prolonged for an additional 4 h. Transwell filters were cut and fixed in 2% paraformaldehyde. Cells were then permeabilized by immersion in 1% saponin in PBS containing 0.1% Triton X-100 (PBS-T) and incubated for 30 min in blocking solution containing 1% BSA in PBS-T and 10% normal goat serum. Primary antibodies were diluted in 1% BSA in PBS-T and incubated for 60 min at room temperature. After they were washed, Alexa Fluor-conjugated secondary antibodies (Molecular Probes) plus phalloidin were incubated for 20 min at room temperature. PET membranes were mounted on glass slides with Slow Fade reagent kit (Molecular Probes) before they were viewed on a Bio-Rad confocal scanning microscope. 3-dimensional reconstruction images were created using Volocity software, version 3.6 (Improvision).
RESULTS

Binding of recombinant pilus components to human epithelial cells.
We investigated the binding of the recombinant forms of the surface-exposed pilus components to epithelial cells. The adhesive properties of PI-1 and PI-2a backbone and ancillary protein 1 were tested in in vitro cellular models of epithelial tissues, such as cervical (ME180), intestinal (Caco2), and pulmonary (A549) cell lines. Because GBS in vivo colonizes the lower gastrointestinal tract and the genital tract of healthy adults and induces pneumonia and respiratory distress during neonatal infection, we consider these cellular models particularly appropriate. Indeed, to gain access to the blood circulation, GBS transverse mucosal barriers such as the cervical/vaginal epithe- Epithelial cells were incubated for 1 h at 4°C with 10 g/mL of each recombinant pilus component. Cells were then incubated with the respective mouse antiserum, followed by FITC-conjugated secondary antibodies, and analyzed by flow cytometry. Black histograms represent negative control cells (i.e., those without recombinant proteins) that were incubated with the respective mouse antiserum, followed by fluorescent-conjugated secondary antibodies. Binding fluorescence shifts were statistically significant, as assessed by the Kolmogorov-Smirnov test.
rescence shifts in ME180 cells is reported in table 1. These data suggest that ancillary pilus proteins may play a role in bacterial adhesion to host cells. In addition, our data suggest that the role of pilus backbone components in cell attachment may vary between the 2 alleles.
Involvement of PI-1 and PI-2a AP1 in GBS adhesion to ME180 epithelial cells. To demonstrate that the expression of pilus components was associated with a functional adhesive phenotype, we compared levels of adherence to epithelial cells between wild-type GBS strains and mutant strains. As reference strains, we chose the COH1 strain, which contains both PI-1 and PI-2b loci, and the 515 strain, which contains the PI-2a locus exclusively. Elsewhere, transmission electron microscopy revealed that both strains express pili [2, 3] . We initially observed that a mutant strain for PI-1 AP1 bound significantly less to epithelial cells, compared with wild-type COH1 ( figure 2A ). This impaired adhesive phenotype was completely restored by transforming the COH1⌬AP1-1 mutant strain with the pAM401 plasmid containing the AP1-1 gene ( figure 2A ). On the other hand, when we tested the COH1⌬BP-1 strain, which does not express polymerized pili on the bacterial surface but does express the ancillary proteins in a nonpolymerized form [3] , the capacity of GBS to adhere to epithelial cells was not affected (figure 2A). We suggest that the monomeric form AP1-1 extends beyond the capsule and may still contribute to GBS attachment to host cells. This was demonstrated by FACS analysis of a mutant strain lacking both the capsule and BP-1, which revealed that AP1-1 was still expressed on the bacterial surface (data not shown). To confirm that association to cells was specific, we infected epithelial cells with Streptococcus gordonii, a poorly adherent grampositive bacterium (figure 2A).
The same experimental approach was used to test the role of PI-2a components in the GBS-host interaction. As for the PI-1 backbone protein mutant strain, infection of ME180 cells with the 515⌬BP-2a strain, which does not express pili on bacterial surface, resulted in a level of association comparable to that of the wild-type strain (figure 2B). The mutant strain lacking AP1-2a, the PI-2a ancillary protein had a phenotype that was less adhesive than that of the wild-type strain ( figure 2B ). The reduced adhesive phenotype shown by the 515⌬AP1-2a strain was fully complemented by transformation with the pAM401 plasmid that contained the AP1-2a gene ( figure 2B ). These data indicate that the ability of recombinant BP-2a to slightly bind to ME180 cells does not have an in vivo affect on the adhesion phenotype of GBS. We suggest that, in our in vitro assay, the contribution of BP-2a to GBS adhesiveness may be masked by other adhesins with higher affinity for host ligands. In addition, we cannot exclude the possibility that the monomeric recombi- Contribution of the pilus backbone protein to GBS translocation of differentiated epithelial cells. On the hypothesis that pili play a role in the interaction between GBS and the host, we decided to investigate the function of pilus components in the recently described paracellular translocation of GBS across junctional complexes [11] . To verify the involvement of pili in this mechanism, transcytosis experiments were performed using mutant strains for pilus components. In brief, ME180 cells were grown on polycarbonate transwell filters until fully differentiated, as revealed by achievement of a plateau in transepithelial electric resistance. Infection of ME180 cells was performed as previously described by use of a multiplicity of infection (MOI) of 10 bacteria/cell [11] . At the indicated time points, lower-chamber medium was collected, and samples were used to calculate the number of viable bacteria that had crossed the monolayer. We observed that the COH1⌬BP-1 mutant strain translocated across ME180 cell monolayers less efficiently than the wild-type COH1 strain ( figure 3A) , suggesting that GBS pili may drive bacteria through intercellular junctions. The same behavior was observed using the 515⌬BP-2a mutant strain (figure 3B). These findings suggest that, because of the assembly of backbone proteins [2, 14] , the pilus architectural structure is important for driving bacteria through intercellular junctions. Of interest, the impaired adhesive phenotype shown by the COH1⌬AP1-1 and 515⌬AP1-2a mutant strains did not correlate with a significantly reduced number of these bacteria appearing in the lower chamber of transwell inserts, compared with the wild-type strains (figure 3A and 3B). To confirm the pivotal role of pili backbone proteins in GBS transcytosis, we complemented the BP-1 and BP-2a deletions by transforming the mutants with a plasmid carrying the respective alleles. Results indicated that the translocation phenotype of these complemented strains was almost totally restored to wild-type levels ( figure 3C and 3D ). Of interest, because the same bacterial inoculum (ϳ5 ϫ 10 6 bacteria/well) was used for COH1 and 515 strains in association and transcytosis experiments, it could be evinced that strain 515 carrying exclusively PI-2a translocates the epithelial monolayer more efficiently than strain COH1 expressing both PI-1 and PI-2b. Similar experiments that used a serotype V strain of GBS (2603 V/R) confirmed the involvement of pilus backbone proteins in paracellular translocation (data not shown).
Localization of pili during GBS paracellular translocation. To confirm the involvement of pili in paracellular translocation, we considered it important to monitor the localization of the structures during the passage of GBS through the intercellular space. Unfortunately, we obtained poor staining of bacteria- associated pili during interaction with host cells, using a postembedding immunogold transmission electron microscopy technique (data not shown). We were able to monitor pili localization in translocating bacteria exclusively by using confocal imaging 3D reconstruction techniques. To enhance the number of events during bacterial translocation, we increased the MOI to 100:1 and incubated cells with bacteria for 4 h. As shown in figure 4A , infection of ME180 cells with the COH1⌬BP-1/pAMBP-1 strain, previously characterized to express extremely long pilus-like structures, resulted in a large number of bacteria adhering to the apical surface of epithelial cells. Bacteria delineated the cell perimeter with pili localized ahead of translocating bacteria, supporting the hypothesis of the involvement of such structures during GBS paracellular translocation. Because of the complexity of the resulting image, we opted not to stain actin under these experimental conditions. However, to better visualize the localization of single pili during paracellular translocation, we reduced the MOI to 1:1, maintaining a constant infection time, and added phalloidin to visualize the cellular architecture. As shown in figure 4B, in these experimental conditions we observed pili protruding from adhering/translocating bacteria and apparently heading for the basolateral surface of ME180 cells. The attempt to visualize pili extending from wild-type GBS strains during paracellular translocation failed. This was due to the fact that, in the tested strains (COH1, 515, and JM9130013), pili were not long enough to be detected by confocal microscopy. An example of this is reported in figure 4C , which shows the staining of BP-2a present on the 515 strain.
GBS paracellular translocation under negative gravitational forces. In standard infection protocols, bacteria sus- . Bacteria were stained with mouse polyclonal antisera raised against type III capsular polysaccharide and labeled with Alexa Fluor 568 -conjugated secondary antibody (red), whereas pilus backbone protein was labeled with rabbit polyclonal anti-BP-1 antibody, followed by Alexa Fluor 488 -conjugated secondary antibody (green). B, 3D reconstruction of ME180 epithelial cells infected with the COH1⌬BP-1/pAMBP-1 strain as in (A), except with an MOI of 1:1. Fluorescence staining was performed as in (A). C, 3D reconstruction of ME180 cells infected with strain 515 for 4 h at 37°C (MOI, 10:1). Bacteria were stained with mouse polyclonal antisera raised against type Ia capsular polysaccharide and labelled with Alexa Fluor 568 -conjugated secondary antibody (red), whereas pilus backbone protein was labeled with rabbit polyclonal anti-BP-2a antibody, followed by Alexa Fluor 488 -conjugated secondary antibody (green). 3D immunofluorescence images were reconstructed from 0.5-m confocal optical sections, using Volocity software, version 3.6 (Improvision).
pended in infection medium are added on top of adherent cells and allowed to deposit for 2 h. As shown in figure 5 , under these infection conditions, we observed that pili localized ahead of translocating bacteria. To exclude the influence of gravitational force on the localization of pili ahead of bacteria, we developed a novel in vitro model of GBS infection, in which bacteria bind and translocate through epithelial surfaces against the action of gravity. The system involves upside-down placement of a transwell insert that supports an epithelial monolayer in a test tube containing GBS cultures, thus allowing the apical side of epithelial cells to face bacteria (figure 5A). Moderate rotation of the test tube at ϳ300 rpm during the experiment maintained the bacteria in suspension and forced them to repetitively access the monolayer. In this way, only bacteria that encounter preferential targets are able to firmly adhere to the monolayer, while the remaining bacteria are recycled by the system until they reach a specific cellular target. We named this protocol "inverse infection." After 2 h of infection, rotation was stopped, and adherent bacteria were monitored by confocal imaging for their capacity to translocate through the monolayer. Under these conditions, we observed that GBS organisms were still able to target the cellular perimeter and preferentially translocate through intercellular junctions (figure 5B). To better visualize the contribution of pili to GBS paracytosis of ME180 cells, we used the COH1⌬BP-1/pAMBP-1 strain. As shown in figure 5C , in inverse-infection experiments as in standard infection protocols, GBS targeted the intercellular space with pili still positioned between cells and ahead of bacteria.
DISCUSSION
The findings reported in this article suggest that PI-1 and PI-2a structural pilus components may play a critical role in the ability of GBS to invade host tissues. A role for pilus components during interaction of GBS with host cells has recently been proposed [10, 14] . In particular, Maisey et al. [10] speculated that GBS PI-2a ancillary protein PilA (AP1-2a) promotes the initial contact and attachment of GBS to host cell surfaces, whereas the PI-2a structural protein PilB (BP-2a) mediates initiation of bacterial cellular internalization. However, in our system, GBS intracellular localization was not affected by deletion of any of the pilus proteins (M.S., unpublished observations). Baron et al. [15, 16] recently proposed that the alpha C protein mediates GBS translocation across epithelial barriers by facilitating GBS intracellular invasiveness through binding to glycosaminoglycan on the surface of the host cell. They suggested that GBS entry into host cells and transcytosis may occur by distinct mechanisms. However, in our infection model, the percentage of internalized bacteria is negligible compared with the number of bacteria crossing the monolayer by a paracellular route. On the basis of these results, we hypothesize that in vivo GBS translocation of the epithelial barriers occurs predominantly by intercellular passage. In this context, the proposed role for pili in paracytosis is of particular importance and critical to GBS dissemination in the host. Indeed, during neonatal meningitis, after intrapartum aspiration of infected fluid, invasion through the alveolar epithelium and pulmonary vasculature endothelium is a virulence mechanism by which GBS gains rapid access to the bloodstream from the alveolar space, and transcytosis might be a preferential nondisruptive and fast invasive mechanism.
The COH1 strain expresses both PI-1 and PI-2b pilus components. On the basis of the data reported in this article, we postulate that the PI-1 ancillary protein contributes to the adhesive phenotype of COH1. However, because COH1 still partially binds cells in the absence of AP1-1, we cannot exclude the possibility that the PI-2b components play a part in binding GBS to epithelial cells. Both pilus ancillary proteins, although differently exposed on bacterial surface, were found to coprecipitate with pili [3] . Of interest, deletion of ancillary protein 2, which is not present on the bacterial surface and is unlikely to contribute to GBS interaction with host cells, reduced GBS adhesiveness but did not affect transcytosis (Santi et al., unpublished observations). Unfortunately, we have no explanation for this phenotype. The discrepancy between the capacity of the recombinant Figure 6 . Model for group B Streptococcus (GBS) infection of the epithelial barrier. A, GBS as a commensal colonizer of mucosal surfaces. Bacteria share the niche with the resident flora and do not directly associate to the epithelium. B, GBS initiates the invasive process associated to pathogenesis. In conditions of a reduced mucosal layer, GBS may get access to targets on the epithelial surface and initiate the invasive process.
BP-2a protein to bind host cells and the lack of an adhesive phenotype for the BP-2a deletion strain could be due to the redundancy of ligands on bacterial surface that may mask the contribution of the pilus backbone protein to the attachment of GBS to epithelial cells.
On the basis of previously reported evidence [4, 10] and data reported in this article, we propose a model for pilus-mediated colonization and pathogenesis-associated translocation of mucosal surfaces by GBS. As shown in figure 6A , we divided the GBS infection process into a colonization stage (CS) and a pathogenic stage (PS). During the CS, GBS mainly acts as a commensal by colonizing mucosal surfaces [17] without getting direct access to epithelial barrier surfaces, which can only be colonized by residential flora [18] . At this level, pilus-like proteinaceous appendages may stabilize bacteria complexes [19] . We propose that this scenario may reflect colonization in healthy individuals. On the other hand, in conditions in which the mucus layer is reduced or the residential flora is modified, GBS may get into close contact with epithelial cell surface-associated ligands (figure 6B). We propose that the adhesive properties of pili ancillary proteins may favor the initial attachment of bacteria to host cell surfaces, whereas pili structures would contribute to the paracellular translocation toward the basolateral surface.
Therefore, we suggest that the immune response toward pili, other than inducing protective immunity [6] , may interfere with the capacity of GBS to disseminate into the host. This aspect would be of importance in developing new strategies to combat the life-threatening invasive diseases associated with GBS.
